HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET.

AbstractOBJECTIVE:
We evaluated tumor hypoxia using F-fluoromisonidazole (F-FMISO) PET in relation to the expression of hypoxia-inducible factor-1α (HIF-1α) and p53 in patients with head and neck cancer and compared the results with those obtained using 2-deoxy-2-F-fluoro-D-glucose (F-FDG) PET.
MATERIALS AND METHODS:
A total of 28 tumors (23 primary tumors and five metastatic lymph nodes) from 24 patients with newly diagnosed head and neck cancer were examined with F-FMISO PET and F-FDG PET. The F-FMISO PET images were scaled to the venous blood concentration of F-FMISO activity to produce tumor-to-blood (T/B) values. Hypoxia was defined as a region with a T/B ratio greater than or equal to 1.2. The maximum T/B (T/Bmax) and hypoxic volumes were calculated by region-of-interest analysis. For F-FDG PET, the maximum standardized uptake value (SUVmax) and hypermetabolic volume were calculated by region-of-interest analysis. The expressions of HIF-1α and p53 using immunohistochemistry were estimated in tumor tissue samples.
RESULTS:
A weak correlation was observed between hypoxic volume and T/Bmax (r=0.53, P=0.003) on using F-FMISO PET and between hypermetabolic volume and SUVmax (r=0.38, P=0.046) on using F-FDG PET. The hypoxic volume using F-FMISO PET and hypermetabolic volume using F-FDG PET also showed a weak correlation (r=0.44, P=0.020). The values of F-FMISO hypoxic volume showed a weak correlation with HIF-1α (r=0.40, P=0.037) and p53 (r=0.47, P=0.012) obtained on immunohistochemical examination.
CONCLUSION:
This study demonstrates a weak correlation between hypoxic volume measured by F-FMISO PET and expressions of HIF-1α and p53 in head and neck cancer.
AuthorsTakashi Norikane, Yuka Yamamoto, Yukito Maeda, Nobuyuki Kudomi, Toru Matsunaga, Reiji Haba, Akinori Iwasaki, Hiroshi Hoshikawa, Yoshihiro Nishiyama
JournalNuclear medicine communications (Nucl Med Commun) Vol. 35 Issue 1 Pg. 30-5 (Jan 2014) ISSN: 1473-5628 [Electronic] England
PMID24121312 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Tumor Suppressor Protein p53
  • fluoromisonidazole
  • Fluorodeoxyglucose F18
  • Misonidazole
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biological Transport
  • Female
  • Fluorodeoxyglucose F18 (metabolism)
  • Gene Expression Regulation, Neoplastic
  • Head and Neck Neoplasms (diagnostic imaging, metabolism)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Male
  • Middle Aged
  • Misonidazole (analogs & derivatives, metabolism)
  • Positron-Emission Tomography
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: